Table 1.
A list of the cannabinoid agonists, antagonists and metabolites described in this review.
| Compound | Abbreviation/Nickname | Function/Purpose |
|---|---|---|
| 2-arachidonoyl glycerol | 2-AG | Endogenous CB1/2 receptor agonist |
| Δ9-tetrahydrocannabinol | THC | Cannabinoid CB1/2 receptor agonist |
| 7-hydroxy-THC | 7-OH-THC | THC metabolite |
| 7-oxo-THC | N/A | THC metabolite |
| 8α, 11-dihydroxy-THC | 8α, 11-diOH-THC | THC metabolite |
| 9α, 10α-epoxyhexahydrocannabinol | N/A | THC metabolite |
| 11-hydroxy-THC | 11-OH-THC | Primary THC metabolite |
| Cannabidiol | CBD | Cannabinoid receptor ligand |
| 4-hydroxy-CBD | 4-OH-CBD | CBD metabolite |
| 6-hydroxy-CBD | 6-OH-CBD | CBD metabolite |
| 7-hydroxy-CBD | 7-OH-CBD | CBD metabolite |
| Cannabielsoin | N/A | CBD metabolite |
| CP 55,940 | N/A | CB1/2 receptor agonist |
| L-α-lysophosphatidylinositol | N/A | GPR55 agonist |
| Marinol (dronabinol) | N/A | Oral THC formulation |
| N-arachidonoylethanolamine | Anandamide | Endogenous CB1 receptor agonist |
| Rimonabant | N/A | CB1 receptor antagonist |
| THC-11-oic acid | N/A | THC metabolite |